Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Structure of pathological TDP-43 filaments from ALS with FTLD.
Arseni D, Hasegawa M, Murzin AG, Kametani F, Arai M, Yoshida M, Ryskeldi-Falcon B. Arseni D, et al. Among authors: kametani f. Nature. 2022 Jan;601(7891):139-143. doi: 10.1038/s41586-021-04199-3. Epub 2021 Dec 8. Nature. 2022. PMID: 34880495 Free PMC article.
[Frontotemporal dementia (FTD) and genetic mutations including progranulin gene].
Arai T, Hasegawa M, Nishihara M, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H. Arai T, et al. Among authors: kametani f. Rinsho Shinkeigaku. 2008 Nov;48(11):990-3. doi: 10.5692/clinicalneurol.48.990. Rinsho Shinkeigaku. 2008. PMID: 19198141 Review. Japanese.
[Significance of the TDP-43 deposition in FTLD-U and ALS].
Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H. Hasegawa M, et al. Among authors: kametani f. Rinsho Shinkeigaku. 2008 Nov;48(11):994-7. doi: 10.5692/clinicalneurol.48.994. Rinsho Shinkeigaku. 2008. PMID: 19198142 Review. Japanese.
Identification of casein kinase-1 phosphorylation sites on TDP-43.
Kametani F, Nonaka T, Suzuki T, Arai T, Dohmae N, Akiyama H, Hasegawa M. Kametani F, et al. Biochem Biophys Res Commun. 2009 May 1;382(2):405-9. doi: 10.1016/j.bbrc.2009.03.038. Epub 2009 Mar 13. Biochem Biophys Res Commun. 2009. PMID: 19285963
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Yamashita M, Nonaka T, Arai T, Kametani F, Buchman VL, Ninkina N, Bachurin SO, Akiyama H, Goedert M, Hasegawa M. Yamashita M, et al. Among authors: kametani f. FEBS Lett. 2009 Jul 21;583(14):2419-24. doi: 10.1016/j.febslet.2009.06.042. Epub 2009 Jun 26. FEBS Lett. 2009. PMID: 19560462 Free article.
[TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
Hasegawa M, Nonaka T, Yamashita M, Kametani F, Arai T, Yoshida M, Hashizume Y, Tsuchiya K, Akiyama H. Hasegawa M, et al. Among authors: kametani f. Rinsho Shinkeigaku. 2009 Nov;49(11):783-5. doi: 10.5692/clinicalneurol.49.783. Rinsho Shinkeigaku. 2009. PMID: 20030209 Review. Japanese.
Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, Niizato K, Tsuchiya K, Kobayashi Z, Ikeda K, Yoshida M, Onaya M, Fujishiro H, Akiyama H. Arai T, et al. Among authors: kametani f. Neuropathology. 2010 Apr;30(2):170-81. doi: 10.1111/j.1440-1789.2009.01089.x. Epub 2010 Jan 19. Neuropathology. 2010. PMID: 20102522 Review.
Molecular dissection of TDP-43 proteinopathies.
Hasegawa M, Nonaka T, Tsuji H, Tamaoka A, Yamashita M, Kametani F, Yoshida M, Arai T, Akiyama H. Hasegawa M, et al. Among authors: kametani f. J Mol Neurosci. 2011 Nov;45(3):480-5. doi: 10.1007/s12031-011-9571-x. Epub 2011 Jun 16. J Mol Neurosci. 2011. PMID: 21678031
207 results